BY-244

N/A

Report date: 2022/02/21 11:01:38
NME

Base Information

Drug NameBY-244
Drug Alias NameBY-244
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 1 inhibitors
TargetsPhosphodiesterase 1
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaBronchitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltana Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltana Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthmaBronchitis

Other Information

ATC CodeN/A
Related LinksN/A